Krka DD (XLJU:KRKG) Tax Provision : €-59 Mil (TTM As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Krka DD Tax Provision?

Krka DD's tax provision for the three months ended in Sep. 2024 was €-11 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was €-59 Mil.

Krka DD Tax Provision Historical Data

The historical data trend for Krka DD's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka DD Tax Provision Chart

Krka DD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-40.10

-50.04

-54.27

-69.41

-53.39

Krka DD Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-14.32	-2.34	-19.87	-25.75	-10.68

Krka DD Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-59 Mil.

Krka DD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka DD (XLJU:KRKG) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

KRK:Poland

Address

Smarjeska Cesta 6, Novo Mesto, SVN, 8501

Website

https://www.krka.biz

Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.

Krka DD Headlines

No Headlines